Emergent BioSolutions, Inc. (EBS) reported earnings of 74 cents per share in the fourth quarter of 2016, which surpassed the Zacks Consensus Estimate of 60 cents. However, the reported figure decreased from 77 cents earned in the year-ago period.
- 24/7 Wall St.•yesterday
Celgene shares were trading lower on Friday due to a key management retirement. The problem is that this retirement is just sort out of the blue and was after a rather short tenure.
- Motley Fool•yesterday
Here's why AbbVie, Celgene, and Gilead Sciences are three of the least expensive biotech stocks around.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||117.70 x 200|
|Ask||118.39 x 200|
|Day's Range||117.28 - 119.31|
|52 Week Range||94.39 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||47.48|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|